2 No-Brainer Dividend Stocks to Buy Right Now

Source Motley_fool

Key Points

  • Paying dividends is a priority for both companies.

  • Procter & Gamble has paid dividends for 135 years.

  • Johnson & Johnson has raised the payout for 63 straight years.

  • 10 stocks we like better than Procter & Gamble ›

The stock market has been doing well, and it might seem like that may go on for some time. The S&P 500 gained 16.4% in 2025, and it's off to a good start this year, up 1.1% through Jan. 8.

The market's volatility has been low by historical standards, with the CBOE Volatility Index (VIX, also known as the Fear Index) at 15.7 as of Jan. 8. By comparison, it was more than 60 in early April after the administration announced its initial tariff policy.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

But stocks can't go up forever, and higher volatility will return at some point. Dividend-paying companies typically provide stability. The key is to select strong companies with a commitment and ability to sustain payments in various economic climates.

These two companies, both Dividend Kings (increased payouts for more than 50 straight years), fit the bill.

Someone studying charts.

Image source: Getty Images.

1. Procter & Gamble

Procter & Gamble (NYSE: PG) sells a range of consumer staples, which are products that people need and use in their everyday lives. Its products include shampoos, conditioners, deodorants, razors, detergents, and diapers.

Procter & Gamble sells these items under well-known brands, such as Head & Shoulders, Old Spice, Gillette, Tide, and Pampers. These brands command a high market share.

Despite consumers facing a tough economic climate, Procter & Gamble managed to grow sales. Its fiscal first-quarter (ended Sept. 30) sales grew 2%. Price and mix each contributed 1 percentage point, while volume was flat. Its sales figures have been adjusted to eliminate foreign-currency translation effects and the impact of acquisitions and divestitures.

Management took a cautious approach to guidance, expecting flat to 4% sales growth for the year. Its sales growth may not look great, but when economic conditions improve, Procter & Gamble's top-line growth should increase.

After all, it has popular products and a stable business. It's no wonder the company has paid a dividend for 135 years and raised the payouts for the last 69 straight years. These payments look sustainable, too. Procter & Gamble has a payout ratio of 60%, indicating the company produces plenty of profit to support dividends.

Procter & Gamble's shares have a 3% dividend yield. That's nearly triple the S&P 500 index's 1.1%.

2. Johnson & Johnson

It's hard to imagine, but Johnson & Johnson (NYSE: JNJ) has become purely a healthcare company following its spinoff of the consumer products division. That business became the publicly traded company Kenvue (NYSE: KVUE).

While Johnson & Johnson has planned other steps, such as spinning off its orthopedics business, the company's core business remains finding innovative drugs and medical technology. Its drugs and treatments focus on areas such as immunology (e.g., rheumatoid arthritis), infectious diseases, neuroscience (e.g., schizophrenia), oncology, cardiovascular, and metabolism (e.g., diabetes).

Naturally, its business doesn't depend on the economic cycle. After all, people need their important treatments. In some cases, it's a matter of life or death.

Johnson & Johnson's third-quarter adjusted sales grew 4.4% year over year. Its diluted earnings per share jumped 15.7%.

Its business generates plenty of free cash flow (FCF) to support dividends. During the first nine months of 2025, Johnson & Johnson had FCF of $14.3 billion. That's plenty to pay dividends of $9.3 billion.

While the business has changed, prioritizing dividends remains a focus. Last April, the board of directors increased the quarterly payout by 4.8% to $1.30 a share. That ran the company's streak to 63 consecutive years with a raise.

Johnson & Johnson's stock has a 2.5% dividend yield, more than double that of the S&P 500.

Should you buy stock in Procter & Gamble right now?

Before you buy stock in Procter & Gamble, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Procter & Gamble wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $482,451!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,133,229!*

Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 13, 2026.

Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kenvue. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
US Dollar's Decline Predicted in 2026: Morgan Stanley's Outlook on Currency VolatilityMorgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
Author  Mitrade
Nov 25, 2025
Morgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
placeholder
Oil Rises on Geopolitical Tensions Involving Iran and VenezuelaOil prices extended gains on Friday as traders assessed heightened geopolitical risks, including U.S. President Donald Trump’s warnings against Iran and ongoing efforts to exert influence over Venezuela’s oil exports.
Author  Mitrade
Jan 09, Fri
Oil prices extended gains on Friday as traders assessed heightened geopolitical risks, including U.S. President Donald Trump’s warnings against Iran and ongoing efforts to exert influence over Venezuela’s oil exports.
placeholder
Gold Prices Soar to Record High Amid Disappointing U.S. Jobs Data and Geopolitical Tensions Gold prices surged to a record $4,601.17 per ounce as weaker-than-expected U.S. payroll data heightened expectations for Federal Reserve interest rate cuts. Ongoing geopolitical tensions in the Middle East and Venezuela further supported the metal's appeal as a safe haven.
Author  Mitrade
Yesterday 02: 10
Gold prices surged to a record $4,601.17 per ounce as weaker-than-expected U.S. payroll data heightened expectations for Federal Reserve interest rate cuts. Ongoing geopolitical tensions in the Middle East and Venezuela further supported the metal's appeal as a safe haven.
placeholder
Gold, Silver Hit Records as Fed Independence Fears, Iran Unrest Fuel Haven RushGold and silver surged to all-time highs on Monday, propelled by mounting concerns over Federal Reserve independence after the U.S. Justice Department threatened a criminal indictment against the central bank, alongside escalating geopolitical tensions as protests in Iran intensified.
Author  Mitrade
Yesterday 07: 34
Gold and silver surged to all-time highs on Monday, propelled by mounting concerns over Federal Reserve independence after the U.S. Justice Department threatened a criminal indictment against the central bank, alongside escalating geopolitical tensions as protests in Iran intensified.
placeholder
Australian Consumer Confidence Declines Amid Rising Interest Rate ConcernsConsumer confidence in Australia fell in January, driven by increased worries about interest rates and job security. The Westpac-Melbourne Institute Consumer Sentiment Index remains in pessimistic territory below neutral levels.
Author  Mitrade
10 hours ago
Consumer confidence in Australia fell in January, driven by increased worries about interest rates and job security. The Westpac-Melbourne Institute Consumer Sentiment Index remains in pessimistic territory below neutral levels.
goTop
quote